4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile
97%
- Product Code: 81334
CAS:
1159982-14-5
| Molecular Weight: | 222.04 g./mol | Molecular Formula: | C₈H₄BrN₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11046238 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used in pharmaceutical research as a key intermediate for the synthesis of biologically active compounds. Its structure is valuable in developing inhibitors for various enzymes, particularly kinase inhibitors, which are crucial in cancer therapy. The compound also serves as a building block in organic synthesis, enabling the creation of complex molecules for drug discovery. Its bromo and cyano functional groups make it versatile for further chemical modifications, aiding in the exploration of new therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿1,224.00 |
+
-
|
| 0.250 | 10-20 days | ฿2,880.00 |
+
-
|
| 1.000 | 10-20 days | ฿7,578.00 |
+
-
|
4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile
Used in pharmaceutical research as a key intermediate for the synthesis of biologically active compounds. Its structure is valuable in developing inhibitors for various enzymes, particularly kinase inhibitors, which are crucial in cancer therapy. The compound also serves as a building block in organic synthesis, enabling the creation of complex molecules for drug discovery. Its bromo and cyano functional groups make it versatile for further chemical modifications, aiding in the exploration of new therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :